Share on StockTwits

Perrigo Company PLC (NASDAQ:PRGO) CFO Judy L. Brown unloaded 3,515 shares of the stock in a transaction that occurred on Tuesday, September 2nd. The shares were sold at an average price of $149.32, for a total transaction of $524,859.80. Following the transaction, the chief financial officer now directly owns 7,445 shares in the company, valued at approximately $1,111,687. The sale was disclosed in a document filed with the SEC, which is available at this link.

A number of analysts have recently weighed in on PRGO shares. Analysts at Zacks reiterated a “neutral” rating on shares of Perrigo Company PLC in a research note on Monday, August 18th. They now have a $156.00 price target on the stock. Separately, analysts at B. Riley upgraded shares of Perrigo Company PLC from a “neutral” rating to a “buy” rating in a research note on Friday, August 15th. They now have a $180.00 price target on the stock, up previously from $157.00. Finally, analysts at Jefferies Group raised their price target on shares of Perrigo Company PLC from $160.00 to $176.00 in a research note on Friday, August 15th. They now have a “buy” rating on the stock. Three research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Perrigo Company PLC has an average rating of “Buy” and a consensus target price of $166.92.

Shares of Perrigo Company PLC (NASDAQ:PRGO) traded up 0.66% during mid-day trading on Wednesday, hitting $149.94. The stock had a trading volume of 939,184 shares. Perrigo Company PLC has a 1-year low of $122.12 and a 1-year high of $168.39. The stock’s 50-day moving average is $149. and its 200-day moving average is $148.7. The company has a market cap of $20.065 billion and a P/E ratio of 84.15.

Perrigo Company PLC (NASDAQ:PRGO) last issued its quarterly earnings data on Thursday, August 14th. The company reported $1.74 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.55 by $0.19. The company had revenue of $1.14 billion for the quarter, compared to the consensus estimate of $1.09 billion. Analysts expect that Perrigo Company PLC will post $7.39 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which is scheduled for Tuesday, September 16th. Shareholders of record on Friday, August 29th will be given a dividend of $0.105 per share. This represents a $0.42 dividend on an annualized basis and a yield of 0.28%. The ex-dividend date of this dividend is Wednesday, August 27th.

Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (NASDAQ:PRGO) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.

Receive News & Ratings for Perrigo Company PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo Company PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.